273 related articles for article (PubMed ID: 3857503)
21. [Drug plasma protein binding and pharmacokinetics].
Han GZ; Liu YH
Sheng Li Ke Xue Jin Zhan; 1987 Jul; 18(3):241-5. PubMed ID: 3313711
[No Abstract] [Full Text] [Related]
22. Binding of drugs to alpha 1-acid glycoprotein and its desialylated form. Influence on hepatic disposition and implications for drug targeting to the liver.
Meijer DK; van der Sluijs P
Prog Clin Biol Res; 1989; 300():143-67. PubMed ID: 2674961
[No Abstract] [Full Text] [Related]
23. [The binding of drugs to proteins. I. General significance for drug kinetics].
Trnavská Z; Verner P
Cesk Farm; 1983 Mar; 32(2):88-95. PubMed ID: 6850871
[No Abstract] [Full Text] [Related]
24. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP
Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892
[TBL] [Abstract][Full Text] [Related]
25. Using capillary electrophoresis/frontal analysis to screen drugs interacting with human serum proteins.
McDonnell PA; Caldwell GW; Masucci JA
Electrophoresis; 1998 Mar; 19(3):448-54. PubMed ID: 9551800
[TBL] [Abstract][Full Text] [Related]
26. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
[TBL] [Abstract][Full Text] [Related]
27. Not norepinephrine but its oxidation products bind specifically to plasma proteins.
Boomsma F; Man in 't Veld AJ; Schalekamp MA
J Pharmacol Exp Ther; 1991 Nov; 259(2):551-7. PubMed ID: 1941606
[TBL] [Abstract][Full Text] [Related]
28. The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma.
Plum A; Müller LK; Jansen JA
Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):139-43. PubMed ID: 10893694
[TBL] [Abstract][Full Text] [Related]
29. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
[TBL] [Abstract][Full Text] [Related]
30. [Protein binding of drugs].
Duchier J
Rev Prat; 1980 Jun; 30(35):2293-7. PubMed ID: 7414230
[No Abstract] [Full Text] [Related]
31. Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences between the two enantiomers are partly due to cooperativity.
Mazoit JX; Cao LS; Samii K
J Pharmacol Exp Ther; 1996 Jan; 276(1):109-15. PubMed ID: 8558418
[TBL] [Abstract][Full Text] [Related]
32. Drug therapy. Serum drug concentrations as therapeutic guides.
Koch-Weser J
N Engl J Med; 1972 Aug; 287(5):227-31. PubMed ID: 5037497
[No Abstract] [Full Text] [Related]
33. Symposium on drug protein binding. Biochemical, pharmacokinetic and clinical implications. Stockholm, March 26--28, 1980. Abstracts.
Acta Pharm Suec; 1980; 17(2):65-104. PubMed ID: 7446140
[No Abstract] [Full Text] [Related]
34. Enantioselective plasma protein binding of bimoclomol.
Visy J; Fitos I; Mády G; Urge L; Krajcsi P; Simonyi M
Chirality; 2002 Aug; 14(8):638-42. PubMed ID: 12125033
[TBL] [Abstract][Full Text] [Related]
35. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
[TBL] [Abstract][Full Text] [Related]
36. Nutrition and drug-protein binding.
Gayte-Sorbier A; Airaudo CB
World Rev Nutr Diet; 1984; 43():95-116. PubMed ID: 6382813
[No Abstract] [Full Text] [Related]
37. Clinical pharmacokinetics (second of two parts).
Greenblatt DJ; Koch-Weser J
N Engl J Med; 1975 Nov; 293(19):964-70. PubMed ID: 1101062
[No Abstract] [Full Text] [Related]
38. Physiopathological alterations of alpha 1 acid glycoprotein temporal variations: implications for chronopharmacology.
Bruguerolle B; Arnaud C; Levi F; Focan C; Touitou Y; Bouvenot G
Prog Clin Biol Res; 1989; 300():199-214. PubMed ID: 2674964
[No Abstract] [Full Text] [Related]
39. [The clinical and pharmacological significance of drug binding by blood plasma proteins in the mother-placenta-fetus system].
Bender KI; Lutsevich NF; Lutsevich AN
Vrach Delo; 1991 Nov; (11):35-41. PubMed ID: 1801429
[No Abstract] [Full Text] [Related]
40. Impact of plasma-protein binding on receptor occupancy: an analytical description.
Peletier LA; Benson N; van der Graaf PH
J Theor Biol; 2009 Jan; 256(2):253-62. PubMed ID: 18938179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
